Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed director
Quarterly results
Director departure
|
|
ACHILLION PHARMACEUTICALS INC (ACHN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/30/2020 |
4
| G1 EXECUTION SERVICES, LLC (10% Owner) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed of 10,917 shares
@ $6.3, valued at
$68.8k
Disposed of 14,115,498 shares
@ $6.3, valued at
$88.9M
|
|
| 01/29/2020 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 36,431 shares
@ $6.3, valued at
$229.5k
Disposed/sold 3,393,382 shares
@ $6.3, valued at
$21.4M
Disposed/sold 25,159 shares
@ $6.3, valued at
$158.5k
Disposed/sold 50,000 options to buy
@ $3.1, valued at
$155k
Disposed/sold 20,000 options to buy
@ $7.59, valued at
$151.8k
Disposed/sold 20,000 options to buy
@ $8.64, valued at
$172.8k
Disposed/sold 25,000 options to buy
@ $3.02, valued at
$75.5k
Disposed/sold 25,000 options to buy
@ $13.24, valued at
$331k
Disposed/sold 30,000 options to buy
@ $7.54, valued at
$226.2k
Disposed/sold 30,000 options to buy
@ $4.09, valued at
$122.7k
Disposed/sold 30,000 options to buy
@ $2.9, valued at
$87k
|
|
| 01/29/2020 |
4
| Zelenkofske Steven (EVP, Chief Medical Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 500,000 options to buy
@ $2.49, valued at
$1.2M
Disposed/sold 200,000 options to buy
@ $2.18, valued at
$436k
|
|
| 01/29/2020 |
4
| Verwiel Frank (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 30,000 options to buy
@ $7.54, valued at
$226.2k
Disposed/sold 30,000 options to buy
@ $4.09, valued at
$122.7k
Disposed/sold 30,000 options to buy
@ $2.9, valued at
$87k
Disposed/sold 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/29/2020 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 40,000 shares
@ $6.3, valued at
$252k
Disposed/sold 20,000 options to buy
@ $7.59, valued at
$151.8k
Disposed/sold 30,000 options to buy
@ $7.54, valued at
$226.2k
Disposed/sold 30,000 options to buy
@ $4.09, valued at
$122.7k
Disposed/sold 50,000 options to buy
@ $3.1, valued at
$155k
Disposed/sold 25,000 options to buy
@ $3.02, valued at
$75.5k
Disposed/sold 30,000 options to buy
@ $2.9, valued at
$87k
Disposed/sold 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/29/2020 |
4
| Truitt Joseph (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 3,500 shares
@ $6.3, valued at
$22.1k
Disposed/sold 142,000 options to buy
@ $7.61, valued at
$1.1M
Disposed/sold 100,000 options to buy
@ $7.59, valued at
$759k
Disposed/sold 185,000 options to buy
@ $4.11, valued at
$760.4k
Disposed/sold 632,000 options to buy
@ $3.78, valued at
$2.4M
Disposed/sold 30,000 options to buy
@ $3.66, valued at
$109.8k
Disposed/sold 87,766 options to buy
@ $3.1, valued at
$272.1k
Disposed/sold 200,000 options to buy
@ $3.02, valued at
$604k
Disposed/sold 419,000 options to buy
@ $2.9, valued at
$1.2M
Disposed/sold 1,097,000 options to buy
@ $2.18, valued at
$2.4M
|
|
| 01/29/2020 |
4
| Scheer David (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 29,515 shares
@ $6.3, valued at
$185.9k
Disposed/sold 63,249 shares
@ $6.3, valued at
$398.5k
Disposed/sold 20,000 options to buy
@ $7.59, valued at
$151.8k
Disposed/sold 30,000 options to buy
@ $7.54, valued at
$226.2k
Disposed/sold 30,000 options to buy
@ $4.09, valued at
$122.7k
Disposed/sold 50,000 options to buy
@ $3.1, valued at
$155k
Disposed/sold 25,000 options to buy
@ $3.02, valued at
$75.5k
Disposed/sold 30,000 options to buy
@ $2.9, valued at
$87k
Disposed/sold 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/29/2020 |
4
| MANNING MARTHA E (General Counsel) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 2,500 shares
@ $6.3, valued at
$15.8k
Disposed/sold 215,000 options to buy
@ $2.9, valued at
$623.5k
Disposed/sold 150,000 options to buy
@ $2.18, valued at
$327k
Disposed/sold 110,000 options to buy
@ $6.79, valued at
$746.9k
Disposed/sold 135,000 options to buy
@ $4.11, valued at
$554.9k
|
|
| 01/29/2020 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 30,000 options to buy
@ $7.54, valued at
$226.2k
Disposed/sold 30,000 options to buy
@ $4.09, valued at
$122.7k
Disposed/sold 25,000 options to buy
@ $3.02, valued at
$75.5k
Disposed/sold 30,000 options to buy
@ $2.9, valued at
$87k
Disposed/sold 6,250 options to buy
@ $2.74, valued at
$17.1k
Disposed/sold 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/29/2020 |
4
| Graves Kurt (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 22,709 shares
@ $6.3, valued at
$143.1k
Disposed/sold 30,000 options to buy
@ $7.54, valued at
$226.2k
Disposed/sold 135,000 options to buy
@ $6.12, valued at
$826.2k
Disposed/sold 30,000 options to buy
@ $4.09, valued at
$122.7k
Disposed/sold 25,000 options to buy
@ $3.02, valued at
$75.5k
Disposed/sold 30,000 options to buy
@ $2.9, valued at
$87k
Disposed/sold 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/29/2020 |
4
| Gibney Anthony S (EVP, Chief Business Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 500,000 options to buy
@ $2.53, valued at
$1.3M
Disposed/sold 200,000 options to buy
@ $2.18, valued at
$436k
|
|
| 01/29/2020 |
4
| FISHERMAN JASON S (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 90,000 shares
@ $6.3, valued at
$567k
Disposed/sold 1,500 shares
@ $6.3, valued at
$9.5k
Disposed/sold 20,000 options to buy
@ $7.59, valued at
$151.8k
Disposed/sold 30,000 options to buy
@ $7.54, valued at
$226.2k
Disposed/sold 30,000 options to buy
@ $4.09, valued at
$122.7k
Disposed/sold 50,000 options to buy
@ $3.1, valued at
$155k
Disposed/sold 25,000 options to buy
@ $3.02, valued at
$75.5k
Disposed/sold 30,000 options to buy
@ $2.9, valued at
$87k
Disposed/sold 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/29/2020 |
4
| Firuta Paul E (EVP, Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 400,000 options to buy
@ $3.32, valued at
$1.3M
Disposed/sold 200,000 options to buy
@ $2.18, valued at
$436k
|
|
| 01/29/2020 |
4
| Di Donato Brian (SVP, CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 200,000 options to buy
@ $2.56, valued at
$512k
Disposed/sold 500,000 options to buy
@ $2.29, valued at
$1.1M
|
|
| 12/19/2019 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Exercised 20,000 options to buy
@ $3.28, valued at
$65.6k
|
|
| 11/14/2019 |
4
| FISHERMAN JASON S (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Exercised 20,000 options to buy
@ $3.28, valued at
$65.6k
|
|
| 11/14/2019 |
4
| Scheer David (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 10,485 shares
@ $6.3135, valued at
$66.2k
Exercised 20,000 options to buy
@ $3.28, valued at
$65.6k
|
|
| 10/18/2019 |
4
| Truitt Joseph (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 100,234 shares
@ $6.3749, valued at
$639k
Sold 33,250 shares
@ $6.3749, valued at
$212k
Exercised 33,250 options to buy
@ $3.28, valued at
$109.1k
Exercised 100,234 options to buy
@ $3.1, valued at
$310.7k
|
|
| 02/11/2019 |
4
| Di Donato Brian (CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 500,000 options to buy
@ $2.29, valued at
$1.1M
|
|
| 01/25/2019 |
4
| Verwiel Frank (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/25/2019 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/25/2019 |
4
| Scheer David (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/25/2019 |
4
| KISHBAUCH MICHAEL D (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/25/2019 |
4
| Graves Kurt (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/25/2019 |
4
| FISHERMAN JASON S (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 01/25/2019 |
4
| Zelenkofske Steven (Chief Medical Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $2.18, valued at
$436k
|
|
| 01/25/2019 |
4
| Truitt Joseph (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 1,097,000 options to buy
@ $2.18, valued at
$2.4M
|
|
| 01/25/2019 |
4
| MANNING MARTHA E (General Counsel) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 150,000 options to buy
@ $2.18, valued at
$327k
|
|
| 01/25/2019 |
4
| Lantz Keri (See Remarks) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $2.18, valued at
$218k
|
|
| 01/25/2019 |
4
| Gibney Anthony S (Chief Business Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $2.18, valued at
$436k
|
|
| 01/25/2019 |
4
| Firuta Paul E (COO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $2.18, valued at
$436k
|
|
| 01/25/2019 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 12/18/2018 |
4
| Scheer David (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Exercised 20,000 options to buy
@ $1.05, valued at
$21k
|
|
| 12/18/2018 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Exercised 20,000 options to buy
@ $1.05, valued at
$21k
|
|
|
|
|